Registry Data Evaluating the Effectiveness of Drug-eluting Stents for the Treatment of Symptomatic In-stent Restenosis

Heart Lung and Circulation

Volumn 15, Issue 5, 2006, Pages 300-305

  Worthley, Matthew I ^a   Anderson, Todd J ^a   Traboulsi, Mouhieddin ^a   Charbonneau, Francois ^a   Curtis, Michael J ^a   Hansen, James L ^a   Knudtson, Merril L ^a   Spence, Frank P ^a   Goodhart, David M ^a  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

Drug eluting stents; In stent restenosis; Paclitaxel; Sirolimus

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SAFETY; SYMPTOMATOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PROSTHESIS FAILURE; REOPERATION; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748894185     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2006.06.002     Document Type: Article

References (35)

1. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1 (1978) 4
2. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331 (1994) 489-495
3. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331 (1994) 496-501
4. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
5. Park S.J., Shim W.H., Ho D.S., Raizner A.E., Park S.W., Hong M.K., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348 (2003) 1537-1545
6. Lemos P.A., Serruys P.W., and Sousa J.E. Drug-eluting stents: cost versus clinical benefit. Circulation 107 (2003) 3003-3007
7. Mehran R., Mintz G.S., Popma J.J., Pichard A.D., Satler L.F., Kent K.M., et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 78 (1996) 618-622
8. Alfonso F., Zueco J., Cequier A., Mantilla R., Bethencourt A., Lopez-Minguez J.R., et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 42 (2003) 796-805
9. Moreno R., Fernandez C., Alfonso F., Hernandez R., Perez-Vizcayno N.J., Escaned J., et al. Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol 43 (2004) 1964-1972
10. vom Dahl J., Dietz U., Haager P.K., Silber S., Niccoli L., Buettner H.J., et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 105 (2002) 583-588
11. Giri S., Ito S., Lansky A.J., Mehran R., Margolis J., Gilmore P., et al. Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry. Catheter Cardiovasc Interv 52 (2001) 24-34
12. Adamian M., Colombo A., Briguori C., Nishida T., Marsico F., Di Mario C., et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 38 (2001) 672-679
13. Ajani A.E., Kim H.S., and Waksman R. Clinical trials of vascular brachytherapy for in-stent restenosis: update. Cardiovasc Radiat Med 2 (2001) 107-113
14. Waksman R., Bhargava B., Mintz G.S., Mehran R., Lansky A.J., Satler L.F., et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 36 (2000) 65-68
15. Waksman R., Ajani A.E., White R.L., Chan R., Bass B., Pichard A.D., et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 (2004) 340-344
16. Condado J.A., Waksman R., Gurdiel O., Espinosa R., Gonzalez J., Burger B., et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 96 (1997) 727-732
17. Stone G.W., Ellis S.G., O'Shaughnessy C.D., Martin S.L., Satler L., McGarry T., et al. Paclitaxel-eluting stent vs vascular brachytherapy for in-stent restenosis within bare metal stents: the TAXUS-V ISR randomized trial. JAMA 295 (2006) 1253-1263
18. Holmes Jr. D.R., Teirstein P.S., Satler L., Sketch M., O'Malley J., Popma J.J., et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare metal stents: the SISR randomized trial. JAMA 295 (2006) 1307-1309
19. Neumann F.-J., Desmet W., Grube E., Brachmann J., Presbitero P., Rubartelli P., et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 111 (2005) 2107-2111
20. Degertekin M., Regar E., Tanabe K., Smits P.C., van der Giessen W.J., Carlier S.G., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 41 (2003) 184-189
21. Tanabe K., Serruys P.W., Grube E., Smits P.C., Selbach G., van der Giessen W.J., et al. TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107 (2003) 559-564
22. Saia F., Lemos P.A., Arampatzis C.A., Hoye A., Degertekin M., Tanabe K., et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart 90 (2004) 1183-1188
23. Iofina E., Haager P.K., Radke P.W., Langenberg R., Blindt R., Ortlepp J., et al. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Catheter Cardiovasc Interv 64 (2005) 28-34
24. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
25. Popma J.J., Berger P., Ohman E.M., Harrington R.A., Grines C., and Weitz J.L. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (2004) 576S-599S
26. Mehran R., Dangas G., Abizaid A.S., Minta G.S., Lansky A.J., Satler L.F., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
27. Rajagopal V., and Rockson S.G. Coronary restenosis: a review of mechanisms and management. Am J Med 115 (2003) 547-553
28. Mehilli J., Kastrati A., Schuhlen H., Dibra A., Dotzer F., von Beckerath N., et al. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 110 (2004) 3627-3635
29. Mehran R., Dangas G., Abizaid A., Lansky A.J., Mintz G.S., Pichard A.D., et al. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: short- and long-term results. Am Heart J 141 (2001) 610-614
30. Elezi S., Kastrati A., Hadamitzky M., Dirschinger J., Neumann F.J., and Schomig A. Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv 48 (1999) 151-156
31. Windecker S., Remondino A., Eberli F.R., Juni P., Raber L., Wenaweser P., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
32. Mauri L., Orav E.J., O'Malley A.J., Moses J.W., Leon M.B., Holmes Jr. D.R., et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 111 (2005) 321-327
33. Ellis S.G., Popma J.J., Lasala J.M., Koglin J.J., Cox D.A., Hermiller J., et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1193-1200
34. Rensing B.J., Hermans W.R., Deckers J.W., de Feyter P.F., Tijssen J.G., and Serruys P.W. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near Gaussian distribution: a quantitative angiographic study in 1445 successfully dilated lesions. J Am Coll Cardiol 19 (1992) 939-945
35. Kuntz R.E., and Baim D.S. Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation 88 (1993) 1310-1323